Abstract
Proteoglycans consist of protein cores to which at least one glycosaminoglycan chain is attached. They play important roles in the physiology and biomechanical function of tendons, ligaments, cardiovascular system, and other systems through their involvement in regulation of assembly and maintenance of extracellular matrix, and through their participation in cell proliferation together with growth factors. They can be divided into two main groups, small and large proteoglycans. The small proteoglycans are also known as small leucine-rich proteoglycans (SLRPs) which are encoded by 18 genes and are further subclassified into Classes I-V. Several members of Class I and II, such as decorin and biglycan from Class I, and Class II fibromodulin and lumican, are known to regulate collagen fibrillogenesis. Decorin limits the diameter of collagen fibrils during fibrillogenesis. The function of biglycan in fibrillogenesis is similar to that of decorin. Though biomechanical function of tendon is compromised in decorin-deficient mice, decorin can substitute for lack of biglycan in biglycan-deficient mice. New data also indicate an important role for biglycan in disorders of the cardiovascular system, including aortic valve stenosis and aortic dissection. Two members of the Class II of SLRPs, fibromodulin and lumican bind to the same site within the collagen molecule and can substitute for each other in fibromodulin- or lumican-deficient mice.
Aggrecan and versican are the major representatives of the large proteoglycans. Though they are mainly found in the cartilage where they provide resilience and toughness, they are present also in tensile portions of tendons and, in slightly different biochemical form in fibrocartilage. Degradation by aggrecanase is responsible for the appearance of different forms of aggrecan and versican in different parts of the tendon where these cleaved forms play different roles. In addition, they are important components of the ventricularis of cardiac valves. Mutations in the gene for versican or in the gene for elastin (which binds to versican ) lead to severe disruptions of normal developmental of the heart at least in mice.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ADAMTS:
-
a Disintegrin and metalloproteinase with thrombospondin motifs
- BMP:
-
Bone morphogenetic protein
- CS:
-
Chondroitin sulfate
- DS:
-
Dermatan sulfate
- ECM:
-
Extracellular matrix
- EGF:
-
Epidermal growth factor
- FGF:
-
Fibroblast growth factor
- KS:
-
Keratan sulfate
- LDL:
-
Low density lipoprotein
- LRRs:
-
Leucine-rich repeats
- MMP:
-
Matrix metalloproteinase
- PRELP:
-
Proline and arginine-rich end leucine-rich repeat protein
- SLRP:
-
Small leucine-rich proteoglycan
- TGFβ:
-
Transforming growth factor β
- TNF:
-
Tumor necrosis factor
References
Ameye L, Young MF (2002) Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12(9):107R–116R
Ameye L et al (2002) Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J 16(7):673–680
Aspberg A, Adam S, Kostka G, Timpl R, Heinegård D (1999) Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem 274:20444–20449
Barth M et al (2019) Degenerative aortic valve disease and diabetes: implications for a link between proteoglycans and diabetic disorders in the aortic valve. Diab Vasc Dis Res 16(3):254–269
Bengtsson E, Apberg A, Heinegård D, Sommarin Y, Spillmann D (2000) The amino-terminal part of PRELP binds to heparin and heparan sulfate. J Biol Chem 275:40695–40702
Berenson MC, Blevins FT, Plaas AH, Vogel KG (1996) Proteoglycans of human rotator cuff tendons. J Orthop Res 14:518–525
Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, Shi S, Young MF (2007) Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 13:1219–1227
Bianco P, Fiaher LR, Young MF, Termine JD, Robey PG (1990) Expression and localization of of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38:1549–1563
Bredrup C, Knappskog PM, Majewski J, Rødahl E, Boman H (2005) Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthalmol Vis Sci 46:420–426
Bredrup C, Stang E, Bruland O, Palka BP, Young RD, Haavik J, Knappskog PM, Rødahl E (2010) Decorin accumulation contributes to the stromal opacities found in congenital stromal corneal dystrophy. Invest Ophthalmol Vis Sci 51:5578–5582
Carter DR, Beaupré GS (eds) (2007) Skeletal function and form. Cambridge University Press, Cambridge
Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H (1998) Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 141:1277–1286
Choocheep K, Hatano S, Takagi H, Watanabe H, Kimata K, Kongtawelert P, Watanabe H (2010) Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J Biol Chem 285:21114–21125
Cianfarani F et al (2019) Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa. Matrix Biol 81:3–16
Coady MA, Davies RR, Roberts M, Goldstein LJ, Rogalski MJ, Rizzo JA, Hammond GL, Kopf GS, Elefteriades JA (1999) Familial patterns of thoracic aortic aneurysms. Arch Surg 134:361–367
Corps AN, Jones GC, Harrall RL, Curry VA, Hazleman BL, Riley GP (2008) The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells. Matrix Biol 27:393–401
Corsi A, Xu T, Chen XD, Boyde A, Liang J, Mankani M, Summer B, Iozzo RV, Eichstetter I, Robey PG, Bianco P, Young MF (2002) Phenotypic effects of bioblycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res 17:1180–1189
Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136:729–743
Day JM, Olin AL, Murdoch AD, Canfield A, Sasaki T, Timpl R, Hardingham TE, Aspberg A (2004) Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins. J Biol Chem 279:12511–12518
Didangelos A, Mayr U, Monaco C, Mayr M (2012) Novel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis. J Biol Chem 287:19341–19345
Dunkman AA, Buckley MR, Mienaltowski MJ, Adams SM, Thomas SJ, Satchell L, Kumar A, Pathmanathan L, Beason DP, Iozzo RV, Birk DE, Soslowsky LJ (2013) Decorin expression is important for age-related changes in tendon structure and mechanical properties. Matrix Biol 32:3–13
Engel MB, Zerlotti E (1967) Changes in cells, matrix and water of calcifying turkey leg tendons. Am J Anat 120:489–525
Halper J (2021) Major proteins of the extracellular proteins. In: Allewell NM (ed) Encyclopedia of biological chemistry. Elsevier, Amsterdam
Hatano S, Kimata K, Hiraiwa N, Kusakabe M, Isogai Z, Adachi E, Shinomura T, Watanabe H (2012) Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development. Glycobiology 22:1268–1277
Hedbom E, Heinegård D (1989) Interaction of a 59-dDa connective tissue matrix protein with collagen I and collagen II. J Biol Chem 264:6898–6905
Hedlund H, Mengarelli-Widholm S, Heinegård D, Reinholt FP, Svensson O (1994) Fibromodulin distribution and association with collagen. Matrix Biol 14:227–232
Heegaard AM, Corsi A, Danielsen CC, Nielsen KL, Jorgensen HL, Riminucci M, Young MF, Bianco P (2012) Biglycan deficiency causes spontaneous dissection and rupture in mice. Circulation 115:2731–2738
Heinegård D (2009) Proteoglycans and more – from molecules to biology. Int J Exp Pathol 70:575–586
Hemmeryckx B, Carai P, Roger Lijnen H (2019) ADAMTS5 deficiency in mice does not affect cardiac function. Cell Biol Int 43(6):593–604
Hildebrand A, Romaris M, Rasmussen IM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth beta. Biochem J 302:527–534
Hinton RBJ, Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE (2006) Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 98:1431–1438
Huang R, Merrilees MJ, Braun K, Beaumont B, Lemire J, Clowes AW, Hinek A, Wight TN (2006) Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res 98:370–377
Huang C et al (2019) Novel variants in the KERA gene cause autosomal recessive cornea plana in a Chinese family: a case report. Mol Med Rep 19(6):4711–4718
Ikegawa S (2008) Expression, regulation and function of asporin, a susceptibility gene in common bone and joint diseases. Curr Med Chem 15:724–728
Iozzo RV (1998) Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67:609–652
Iozzo RV (1999) The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 274:18843–18846
Iozzo RV (2007) The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Mol Biol Cell 32:141–174
Iozzo RV, Murdoch AD (1996) Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity of function. FASEB J 10:598–614
Iozzo RV, Schaefer L (2010) Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 277:3864–3875
Iozzo RV, Schaefer L (2015) Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol 42:11–55
Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, Ezura Y, Oldberg Å, Birk DE, Chakravarti S (2002) A syndrome of joint laxity and impaired joint integrity in lumican- and fibromodulin-deficient mice. J Biol Chem 277:35532–35540
Kalamajski S, Aspberg A, Lindblom K, Heinegård D, Oldberg Ǻ (2009) Asporin competes with decorin for collagen bidnign, binds calcium and promotes osteoblast collagen mineralization. Biochem J 423:534–539
Kamma-Loger CS et al (2016) Role of decorin core protein in collagen organisation in congenital stromal corneal dystrophy (CSCD). PLoS One 11:e0147948
Kram V et al (2020) Biglycan in the skeleton. J Histochem Cytochem 68(11):747–762
Krishnamurthy VK, Opoka AM, Kern CB, Guilak F, Narmoneva DA, Hinton RB (2012) Maladaptive matrix remodeling and regional biomechanical dysfunction in a mouse model of aortic valve disease. Matrix Biol 31:197–205
Krusius T, Ruoslahti E (1986) Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci U S A 83:7683–7687
Kuo CK, Petersen BC, Tuan RS (2008) Spatiotemporal protein distribution of TGFβs, their receptors, and extracellular matrix molecules during embryonic tendon development. Dev Dyn 237:1477–1489
Lechner BE, Lim JH, Mercado ML, Fallon JR (2006) Developmental regulation of biglycan expression in muscle and tendon. Muscle Nerve 34:347–355
Lin AE, Lippe BM, Geffner ME, Gomes A, Lois JF, Barton CW, Rosenthal A, Friedman WF (1986) Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr 109:820–826
Lincoln J, Lange AW, Yutzey KE (2006) Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev Biol 294:292–302
Maccarana M et al (2017) Asporin-deficient mice have tougher skin and altered skin glycosaminoglycan content and structure. PLoS One 12(8):e0184028
Manning PL, Morris PM, McMahon A, Jones E, Gize A, Macquaker JH, Wolff G, Thompson A, Marshall J, Taylor KG, Lyson T, Gaskell S, Reamtong O, Sellers WI, van Dongen BE, Buckley M, Wogelius RA (2009) Mineralized soft-tissue structure and chemistry in a mummified hadrosaur from the Hell Creek Formation, North Dakota (USA). Proc Biol Sci 276:3429–3437
McEwan PA, Scott PG, Bishop PN, Bella J (2006) Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J Struct Biol 155:294–305
Meester JA et al (2017) Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections. Genet Med 19(4):386–395
Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR (1998) The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 202:56–66
Mohammadzadeh N et al (2019) The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload. Sci Rep 9(1):9206
Mohammadzadeh N et al (2020) Moderate loss of the extracellular matrix proteoglycan Lumican attenuates cardiac fibrosis in mice subjected to pressure overload. Cardiology 145(3):187–198
Munteanu SE, Ilic MZ, Handley CJ (2002) Highly sulfated glycosminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant culture. Matrix Biol 21:429–440
Ohta K, Kuriyama S, Okafuji T, Gejima R, Ohnuma S, Tanaka H (2006) Tsukushi cooperates with VG1 to induce primitive streak and Hensen's node formation in the chick embryo. Development 133:3777–3786
Olin AI, Mörgelin M, Sasaki T, Timpl R, Heinegård D, Aspberg A (2001) The proteoglycans aggrecan and versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem 276:1253–1261
Önnerfjord PH, Heathfield TF, Heinegård D (2004) Identification of tyrosine sulfation in extracellular leucine-rich repeat proteins using mass spectrometry. J Biol Chem 279:26–33
Parkinson J, Samiric T, Ilic MZ, Cook J, Handley CJ (2011) Involvement of proteoglycans in tendinopathy. J Musculoskelet Neuronal Interact 11:86–93
Pietraszek-Gremplewicz K et al (2019) Small leucine-rich proteoglycans and matrix metalloproteinase-14: key partners? Matrix Biol 75–76:271–285
Plaas A, Sandy JD, Liu H, Diaz MA, Schenkman D, Magnus RP, Bolam-Bretl C, Kopesky PW, Wang VM, Galante JO (2011) Biochemical identification and immunolocalization of aggrecan, ADAMTS5 and inter-alpha-trypsin-inhibitor in equine degenerative suspensory ligament desmitis. J Orthop Res 29:900–906
Polley A et al (2020) Asporin reduces adult aortic valve interstitial cell mineralization induced by osteogenic media and Wnt signaling manipulation in vitro. Int J Cell Biol 2020:2045969
Rada JA, Schrecengost PK, Hassell JR (1993) Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core protein. Exp Eye Res 56:635–648
Reed CC, Iozzo RV (2003) The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J 19:249–255
Rees SG, Flannery CR, Little CB, Hughes CE, Caterson B, Dent CM (2000) Catabolism of aggrecan, decorin and biglycan in tendon. Biochem J 350:181–188
Rees SG, Dent CM, Caterson B (2009) Metabolism of proteoglycans in tendon. Scand J Med Sci Sports 19:470–478
Ren P et al (2017) Critical role of ADAMTS-4 in the development of sporadic aortic aneurysm and dissection in mice. Sci Rep 7(1):12351
Samiric T, Ilic MZ, Handley CJ (2004) Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon. Matrix Biol 23:127–140
Samiric T, Parkinson J, Ilic MZ, Cook J, Feller JA, Handley CJ (2009) Changes in the composition of the extracellular matrix in patellar tendinopathy. Matrix Biol 28:230–236
Santra M, Reed CC, Iozzo RV (2002) Decorin binds to a narrow region of the EGF receptor, partially overlapping with, but distinct from, the EGF-binding epitope. J Biol Chem 277:35671–35681
Schaefer L, Iozzo RV (2008) Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 283:21305–21309
Schönherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H (1995a) Interaction of biglycan with type I collagen. J Biol Chem 270:2776–2783
Schönherr E, Hausser E, Beavan L, Kresse H (1995b) Decorin-type I collagen interaction. Presence of separate core protein-binding domains. J Biol Chem 270:8877–8883
Schönherr E, Broszat M, Brandan E, Bruckner P, Kresse H (1998) Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Arch Biochem Biophys 355:241–248
Shelton EL, Yutzey KE (2007) Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression. Dev Biol 302:376–388
Shelton EL, Yutzey KE (2008) Twist1 function in endocardial cushion cell proliferation, migration, and differentiation during heart valve development. Dev Biol 317:282–295
Shimizu-Hirota R, Sasamura H, Kuroda M, Kobayashi E, Saruta T (2004) Functional characterization of podocan, a member of a new class in the small leucine-rich repeat protein family. FEBS Lett 563:69–74
Song R, Zeng Q, Ao L, Yu JA, Cleveland JC, Zhao KS, Fullerton DA, Meng X (2012) Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2. Arterioscler Thromb Vasc Biol 32:2711–2720
Song R et al (2015) BMP-2 and TGF-beta1 mediate biglycan-induced pro-osteogenic reprogramming in aortic valve interstitial cells. J Mol Med (Berl) 93(4):403–412
Spiesz EM, Roschger P, Zysset PK (2012) Influence of mineralization and microporosity on tissue elasticity: experimental and numerical investigation on mineralized turkey leg tendons. Calcif Tissue Int 90:319–329
Stattin EL, Wiklund F, Lindblom K, Onnerfjord P, Jonsson BA, Tegner Y, Sasaki T, Struglics A, Lohmander S, Dahl N, Heinegård D, Aspberg A (2010) A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans. Am J Hum Genet 86:126–137
Ström A, Ahlqvist E, Franzen A, Heinegård D, Hultgårdh-Nilsson A (2004) Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor deficient mice: an immunohistochemical study. Histol Histopathol 19:337–347
Svensson L, Aszódi A, Reinholt FP, Fässler R, Heinegård D, Oldberg A (1999) Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 274:9636–9647
Svensson L, Närlid I, Oldberg Å (2000) Fibromodulin and lumican bind to the same region on collagen type I fibrils. FEBS Lett 470:178–182
Tanaka N et al (2019) Expression of minor cartilage collagens and small leucine rich proteoglycans may be relatively reduced in osteoarthritic cartilage. BMC Musculoskelet Disord 20(1):232
Tiedemann K, Olander B, Eklund E, Todorova L, Bengtsson M, Maccarana M, Westergren-Thorsson G, Malmström A (2005) Regulation of the chondroitin/dermatan fine structure by transforming growth factor-β1 through effects on polymer-modifying enzymes. Glycobiology 15:1277–1285
Tsuzaki M, Guyton G, Garrett W, Archambault JM, Herzog W, Almekinders L, Bynum D, Yang X, Banes AJ (2003) IL-1 beta induces COX2, MMP-1,-3 and −13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res 21:256–264
Valhmu WB, Stazzone EJ, Bachrach NM, Saed-Nejad F, Fischer SG, Mow VC, Ratcliffe A (1998) Load-controlled compression of articular cartilage induces a transient stimulation of aggrecan gene expression. Arch Biochem Biophys 353:29–36
Viola M (2007) Fibromodulin interactions with type I and II collagens. Connect Tissue Res 48:141–148
Visse MR, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839
Vogel KS, Sandy JD, Pogány G, Robbins JR (1994) Aggrecan in bovine tendon. Matrix Biol 14:171–179
Wiberg C, Heinegard D, Wenglen C, Timpl R, Morgelin M (2002) Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J Biol Chem 277:49120–49126
Wight T (2002) Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14:617–623
Wu YJ, Lapierre D, Wu J, Yee AJ, Yang BB (2005) The interaction of versican with its binding partners. Cell Res 15:483–494
Xiao D et al (2020) Lumican promotes joint fibrosis through TGF-beta signaling. FEBS Open Biol 10(11):2478–2488
Yeo TK, Torok MA, Kraus HL, Evans SA, Zhou Y, Marcum JA (1995) Distribution of biglycan and its propeptide form in rat and bovine aortic tissue. J Vasc Res 32:175–182
Yoon JH, Halper J (2005) Tendon proteoglycans: biochemistry and function. J Musculoskelet Neuronal Interact 5:22–34
Young MF, Bi Y, Ameye L, Chen XD (2002) Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J 19:257–262
Zhang G, Ezura Y, Chervoneva I, Robinson PS, Beason DP, Carine ET, Soslowsky LJ, Iozzo RV, Birk DE (2006) Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development. J Cell Biochem 98:1436–1449
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hwang, C.T., Halper, J. (2021). Proteoglycans and Diseases of Soft Tissues. In: Halper, J. (eds) Progress in Heritable Soft Connective Tissue Diseases. Advances in Experimental Medicine and Biology, vol 1348. Springer, Cham. https://doi.org/10.1007/978-3-030-80614-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-80614-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80613-2
Online ISBN: 978-3-030-80614-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)